Chronic rhinosinusitis with nasal polyps (CRSwNP) is a disease with a significant impact on quality of life. The overall goal of CRSwNP management, as with other chronic conditions, is to achieve “disease control”, and for that reason, a definition of control of disease is pivotal in deciding the best treatment strategy. Although many staging systems have already been developed to evaluate the disease, disease control is not yet to be standardized, and a specific tool that is consistently applied and accepted by all practitioners is still missing in daily clinical practice. To gain an overview of the implementation and limitations of existing guidelines and to shed light on real-life definitions of control and disease severity, we conducted a nationwide survey of otorhinolaryngologists routinely treating CRSwNP to identify unmet clinical needs in Italy. The results showed homogeneous responses regarding the knowledge contained in international guidelines while highlighting the difficulty of their implementation in day-to-day practice. Respondents called attention to the importance of clinical symptoms, giving more weight to the patient’s perspective. Among the symptoms to be considered, respondents emphasized nasal obstruction, followed by loss of sense of smell and rhinorrhea. Others also believe that the physician’s perspective should be considered, and the inclusion of endoscopy as a measure of control was warranted by many. The need for a specific tool that is able to unequivocally ascertain disease control is increasingly pivotal in this new era of biologics for treating CRSwNP.

Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice / De Corso, E., Ottaviano, G., Pipolo, C., Cantone, E., Mattavelli, D., Alicandri-Ciufelli, M., Lucidi, D., Caminati, M., Senna, G., Cavaliere, C., Ghidini, A., Gallo, S., Macchi, A., Torretta, S., Seccia, V., Garzaro, M., Fadda, G.L., Trimarchi, M., Pasquini, E., Pagella, F., et al.. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - 13:11(2023), pp. 15-20. [10.3390/jpm13111531]

Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice

Alicandri-Ciufelli M.
Investigation
;
Lucidi D.;Ghidini A.;Macchi A.;
2023

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a disease with a significant impact on quality of life. The overall goal of CRSwNP management, as with other chronic conditions, is to achieve “disease control”, and for that reason, a definition of control of disease is pivotal in deciding the best treatment strategy. Although many staging systems have already been developed to evaluate the disease, disease control is not yet to be standardized, and a specific tool that is consistently applied and accepted by all practitioners is still missing in daily clinical practice. To gain an overview of the implementation and limitations of existing guidelines and to shed light on real-life definitions of control and disease severity, we conducted a nationwide survey of otorhinolaryngologists routinely treating CRSwNP to identify unmet clinical needs in Italy. The results showed homogeneous responses regarding the knowledge contained in international guidelines while highlighting the difficulty of their implementation in day-to-day practice. Respondents called attention to the importance of clinical symptoms, giving more weight to the patient’s perspective. Among the symptoms to be considered, respondents emphasized nasal obstruction, followed by loss of sense of smell and rhinorrhea. Others also believe that the physician’s perspective should be considered, and the inclusion of endoscopy as a measure of control was warranted by many. The need for a specific tool that is able to unequivocally ascertain disease control is increasingly pivotal in this new era of biologics for treating CRSwNP.
2023
13
11
15
20
Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice / De Corso, E., Ottaviano, G., Pipolo, C., Cantone, E., Mattavelli, D., Alicandri-Ciufelli, M., Lucidi, D., Caminati, M., Senna, G., Cavaliere, C., Ghidini, A., Gallo, S., Macchi, A., Torretta, S., Seccia, V., Garzaro, M., Fadda, G.L., Trimarchi, M., Pasquini, E., Pagella, F., et al.. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - 13:11(2023), pp. 15-20. [10.3390/jpm13111531]
De Corso, E.; Ottaviano, G.; Pipolo, C.; Cantone, E.; Mattavelli, D.; Alicandri-Ciufelli, M.; Lucidi, D.; Caminati, M.; Senna, G.; Cavaliere, C.; Ghid...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1424786
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact